Skip to main content

Peer Review reports

From: Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer

Original Submission
16 May 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
4 Jun 2021 Reviewed Reviewer Report - Nozomu Machida
15 Jun 2021 Reviewed Reviewer Report
15 Jun 2021 Reviewed Reviewer Report - Atsuo Takashima
16 Jun 2021 Reviewed Reviewer Report - Yasushi Sato
8 Jul 2021 Author responded Author comments - Noriyuki Hirahara
Resubmission - Version 3
8 Jul 2021 Submitted Manuscript version 3
22 Jul 2021 Reviewed Reviewer Report - Yasushi Sato
1 Aug 2021 Reviewed Reviewer Report - Atsuo Takashima
30 Aug 2021 Author responded Author comments - Noriyuki Hirahara
Resubmission - Version 4
30 Aug 2021 Submitted Manuscript version 4
4 Sep 2021 Reviewed Reviewer Report - Yasushi Sato
14 Sep 2021 Reviewed Reviewer Report - Atsuo Takashima
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
16 Sep 2021 Editorially accepted
1 Oct 2021 Article published 10.1186/s12885-021-08795-4

You can find further information about peer review here.

Back to article page